Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Dissolving Microneedle Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Dissolving Microneedle Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 141 Pages
Report ld: 5347345
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Dissolving Microneedle market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Drug Delivery accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Dissolving Microneedle leading manufacturers including Micron Biomedical, BioSerenTach, Quadmedicine, Vaxess, Raphas, Youwe Biotech, CosMED Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Micron Biomedical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Dissolving Microneedle market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Micron Biomedical
- BioSerenTach
- Quadmedicine
- Vaxess
- Raphas
- Youwe Biotech
- CosMED Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Polyvinylalcohol, PVA
- Polyvinylpyrrolidone, PVP
- Hyaluronicacid, HA
- Dextran, Dex
- Chitosan, CS
- Sodiumalginate, SA
- Others
Segment by Application
- Drug Delivery
- Vaccine Delivery
CHAPTER OUTLINE
Chapter 1: Defines the Dissolving Microneedle study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Dissolving Microneedle: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Dissolving Microneedle Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Polyvinylalcohol, PVA
1.2.3 Polyvinylpyrrolidone, PVP
1.2.4 Hyaluronicacid, HA
1.2.5 Dextran, Dex
1.2.6 Chitosan, CS
1.2.7 Sodiumalginate, SA
1.2.8 Others
1.3 Market Segmentation by Application
1.3.1 Global Dissolving Microneedle Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Drug Delivery
1.3.3 Vaccine Delivery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dissolving Microneedle Revenue Estimates and Forecasts 2020-2031
2.2 Global Dissolving Microneedle Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Dissolving Microneedle Sales Estimates and Forecasts 2020-2031
2.4 Global Dissolving Microneedle Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Dissolving Microneedle Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Dissolving Microneedle Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Polyvinylalcohol, PVA Market Size by Manufacturers
3.5.2 Polyvinylpyrrolidone, PVP Market Size by Manufacturers
3.5.3 Hyaluronicacid, HA Market Size by Manufacturers
3.5.4 Dextran, Dex Market Size by Manufacturers
3.5.5 Chitosan, CS Market Size by Manufacturers
3.5.6 Sodiumalginate, SA Market Size by Manufacturers
3.5.7 Others Market Size by Manufacturers
3.6 Global Dissolving Microneedle Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Dissolving Microneedle Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Dissolving Microneedle Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Dissolving Microneedle Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Dissolving Microneedle Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Dissolving Microneedle Sales and Revenue by Type (2020-2031)
6.4 North America Dissolving Microneedle Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Dissolving Microneedle Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Dissolving Microneedle Sales and Revenue by Type (2020-2031)
7.4 Europe Dissolving Microneedle Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Dissolving Microneedle Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Dissolving Microneedle Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Dissolving Microneedle Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Dissolving Microneedle Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Dissolving Microneedle Sales and Revenue by Type (2020-2031)
9.4 Central and South America Dissolving Microneedle Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Dissolving Microneedle Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Dissolving Microneedle Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Dissolving Microneedle Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Dissolving Microneedle Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Micron Biomedical
11.1.1 Micron Biomedical Corporation Information
11.1.2 Micron Biomedical Business Overview
11.1.3 Micron Biomedical Dissolving Microneedle Product Models, Descriptions and Specifications
11.1.4 Micron Biomedical Dissolving Microneedle Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Micron Biomedical Dissolving Microneedle Sales by Product in 2024
11.1.6 Micron Biomedical Dissolving Microneedle Sales by Application in 2024
11.1.7 Micron Biomedical Dissolving Microneedle Sales by Geographic Area in 2024
11.1.8 Micron Biomedical Dissolving Microneedle SWOT Analysis
11.1.9 Micron Biomedical Recent Developments
11.2 BioSerenTach
11.2.1 BioSerenTach Corporation Information
11.2.2 BioSerenTach Business Overview
11.2.3 BioSerenTach Dissolving Microneedle Product Models, Descriptions and Specifications
11.2.4 BioSerenTach Dissolving Microneedle Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 BioSerenTach Dissolving Microneedle Sales by Product in 2024
11.2.6 BioSerenTach Dissolving Microneedle Sales by Application in 2024
11.2.7 BioSerenTach Dissolving Microneedle Sales by Geographic Area in 2024
11.2.8 BioSerenTach Dissolving Microneedle SWOT Analysis
11.2.9 BioSerenTach Recent Developments
11.3 Quadmedicine
11.3.1 Quadmedicine Corporation Information
11.3.2 Quadmedicine Business Overview
11.3.3 Quadmedicine Dissolving Microneedle Product Models, Descriptions and Specifications
11.3.4 Quadmedicine Dissolving Microneedle Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Quadmedicine Dissolving Microneedle Sales by Product in 2024
11.3.6 Quadmedicine Dissolving Microneedle Sales by Application in 2024
11.3.7 Quadmedicine Dissolving Microneedle Sales by Geographic Area in 2024
11.3.8 Quadmedicine Dissolving Microneedle SWOT Analysis
11.3.9 Quadmedicine Recent Developments
11.4 Vaxess
11.4.1 Vaxess Corporation Information
11.4.2 Vaxess Business Overview
11.4.3 Vaxess Dissolving Microneedle Product Models, Descriptions and Specifications
11.4.4 Vaxess Dissolving Microneedle Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Vaxess Dissolving Microneedle Sales by Product in 2024
11.4.6 Vaxess Dissolving Microneedle Sales by Application in 2024
11.4.7 Vaxess Dissolving Microneedle Sales by Geographic Area in 2024
11.4.8 Vaxess Dissolving Microneedle SWOT Analysis
11.4.9 Vaxess Recent Developments
11.5 Raphas
11.5.1 Raphas Corporation Information
11.5.2 Raphas Business Overview
11.5.3 Raphas Dissolving Microneedle Product Models, Descriptions and Specifications
11.5.4 Raphas Dissolving Microneedle Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Raphas Dissolving Microneedle Sales by Product in 2024
11.5.6 Raphas Dissolving Microneedle Sales by Application in 2024
11.5.7 Raphas Dissolving Microneedle Sales by Geographic Area in 2024
11.5.8 Raphas Dissolving Microneedle SWOT Analysis
11.5.9 Raphas Recent Developments
11.6 Youwe Biotech
11.6.1 Youwe Biotech Corporation Information
11.6.2 Youwe Biotech Business Overview
11.6.3 Youwe Biotech Dissolving Microneedle Product Models, Descriptions and Specifications
11.6.4 Youwe Biotech Dissolving Microneedle Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Youwe Biotech Recent Developments
11.7 CosMED Pharmaceutical
11.7.1 CosMED Pharmaceutical Corporation Information
11.7.2 CosMED Pharmaceutical Business Overview
11.7.3 CosMED Pharmaceutical Dissolving Microneedle Product Models, Descriptions and Specifications
11.7.4 CosMED Pharmaceutical Dissolving Microneedle Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 CosMED Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Dissolving Microneedle Industry Chain
12.2 Dissolving Microneedle Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Dissolving Microneedle Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Dissolving Microneedle Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Dissolving Microneedle Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Dissolving Microneedle Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Dissolving Microneedle Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Dissolving Microneedle Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Dissolving Microneedle Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Dissolving Microneedle Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dissolving Microneedle Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Dissolving Microneedle Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Dissolving Microneedle Sales by Region (2020-2025) & (K Units)
Table 8. Global Dissolving Microneedle Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Dissolving Microneedle Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Dissolving Microneedle Sales Share by Manufacturers (2020-2025)
Table 12. Global Dissolving Microneedle Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Dissolving Microneedle Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Dissolving Microneedle by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dissolving Microneedle as of 2024)
Table 16. Global Dissolving Microneedle Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Dissolving Microneedle Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Dissolving Microneedle Manufacturing Base and Headquarters
Table 19. Global Dissolving Microneedle Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Dissolving Microneedle Sales by Type (2020-2025) & (K Units)
Table 23. Global Dissolving Microneedle Sales by Type (2026-2031) & (K Units)
Table 24. Global Dissolving Microneedle Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Dissolving Microneedle Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Dissolving Microneedle ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Dissolving Microneedle Sales by Application (2020-2025) & (K Units)
Table 29. Global Dissolving Microneedle Sales by Application (2026-2031) & (K Units)
Table 30. Dissolving Microneedle High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Dissolving Microneedle Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Dissolving Microneedle Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Dissolving Microneedle ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Dissolving Microneedle Growth Accelerators and Market Barriers
Table 37. North America Dissolving Microneedle Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Dissolving Microneedle Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Dissolving Microneedle Growth Accelerators and Market Barriers
Table 40. Europe Dissolving Microneedle Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Dissolving Microneedle Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Dissolving Microneedle Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Dissolving Microneedle Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Dissolving Microneedle Growth Accelerators and Market Barriers
Table 45. Southeast Asia Dissolving Microneedle Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Dissolving Microneedle Investment Opportunities and Key Challenges
Table 47. Central and South America Dissolving Microneedle Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Dissolving Microneedle Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Dissolving Microneedle Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Micron Biomedical Corporation Information
Table 51. Micron Biomedical Description and Major Businesses
Table 52. Micron Biomedical Product Models, Descriptions and Specifications
Table 53. Micron Biomedical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Micron Biomedical Sales Value Proportion by Product in 2024
Table 55. Micron Biomedical Sales Value Proportion by Application in 2024
Table 56. Micron Biomedical Sales Value Proportion by Geographic Area in 2024
Table 57. Micron Biomedical Dissolving Microneedle SWOT Analysis
Table 58. Micron Biomedical Recent Developments
Table 59. BioSerenTach Corporation Information
Table 60. BioSerenTach Description and Major Businesses
Table 61. BioSerenTach Product Models, Descriptions and Specifications
Table 62. BioSerenTach Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. BioSerenTach Sales Value Proportion by Product in 2024
Table 64. BioSerenTach Sales Value Proportion by Application in 2024
Table 65. BioSerenTach Sales Value Proportion by Geographic Area in 2024
Table 66. BioSerenTach Dissolving Microneedle SWOT Analysis
Table 67. BioSerenTach Recent Developments
Table 68. Quadmedicine Corporation Information
Table 69. Quadmedicine Description and Major Businesses
Table 70. Quadmedicine Product Models, Descriptions and Specifications
Table 71. Quadmedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Quadmedicine Sales Value Proportion by Product in 2024
Table 73. Quadmedicine Sales Value Proportion by Application in 2024
Table 74. Quadmedicine Sales Value Proportion by Geographic Area in 2024
Table 75. Quadmedicine Dissolving Microneedle SWOT Analysis
Table 76. Quadmedicine Recent Developments
Table 77. Vaxess Corporation Information
Table 78. Vaxess Description and Major Businesses
Table 79. Vaxess Product Models, Descriptions and Specifications
Table 80. Vaxess Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Vaxess Sales Value Proportion by Product in 2024
Table 82. Vaxess Sales Value Proportion by Application in 2024
Table 83. Vaxess Sales Value Proportion by Geographic Area in 2024
Table 84. Vaxess Dissolving Microneedle SWOT Analysis
Table 85. Vaxess Recent Developments
Table 86. Raphas Corporation Information
Table 87. Raphas Description and Major Businesses
Table 88. Raphas Product Models, Descriptions and Specifications
Table 89. Raphas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Raphas Sales Value Proportion by Product in 2024
Table 91. Raphas Sales Value Proportion by Application in 2024
Table 92. Raphas Sales Value Proportion by Geographic Area in 2024
Table 93. Raphas Dissolving Microneedle SWOT Analysis
Table 94. Raphas Recent Developments
Table 95. Youwe Biotech Corporation Information
Table 96. Youwe Biotech Description and Major Businesses
Table 97. Youwe Biotech Product Models, Descriptions and Specifications
Table 98. Youwe Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Youwe Biotech Recent Developments
Table 100. CosMED Pharmaceutical Corporation Information
Table 101. CosMED Pharmaceutical Description and Major Businesses
Table 102. CosMED Pharmaceutical Product Models, Descriptions and Specifications
Table 103. CosMED Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. CosMED Pharmaceutical Recent Developments
Table 105. Key Raw Materials Distribution
Table 106. Raw Materials Key Suppliers
Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 108. Milestones in Production Technology Evolution
Table 109. Distributors List
Table 110. Market Trends and Market Evolution
Table 111. Market Drivers and Opportunities
Table 112. Market Challenges, Risks, and Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Dissolving Microneedle Product Picture
Figure 2. Global Dissolving Microneedle Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Polyvinylalcohol, PVA Product Picture
Figure 4. Polyvinylpyrrolidone, PVP Product Picture
Figure 5. Hyaluronicacid, HA Product Picture
Figure 6. Dextran, Dex Product Picture
Figure 7. Chitosan, CS Product Picture
Figure 8. Sodiumalginate, SA Product Picture
Figure 9. Others Product Picture
Figure 10. Global Dissolving Microneedle Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 11. Drug Delivery
Figure 12. Vaccine Delivery
Figure 13. Dissolving Microneedle Report Years Considered
Figure 14. Global Dissolving Microneedle Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 16. Global Dissolving Microneedle Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Dissolving Microneedle Revenue Market Share by Region (2020-2031)
Figure 18. Global Dissolving Microneedle Sales (2020-2031) & (K Units)
Figure 19. Global Dissolving Microneedle Sales (CAGR) by Region (2020-2031) (K Units)
Figure 20. Global Dissolving Microneedle Sales Market Share by Region (2020-2031)
Figure 21. Top 5 and Top 10 Manufacturers Dissolving Microneedle Sales Volume Market Share in 2024
Figure 22. Global Dissolving Microneedle Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. Polyvinylalcohol, PVA Revenue Market Share by Manufacturer in 2024
Figure 25. Polyvinylpyrrolidone, PVP Revenue Market Share by Manufacturer in 2024
Figure 26. Hyaluronicacid, HA Revenue Market Share by Manufacturer in 2024
Figure 27. Dextran, Dex Revenue Market Share by Manufacturer in 2024
Figure 28. Chitosan, CS Revenue Market Share by Manufacturer in 2024
Figure 29. Sodiumalginate, SA Revenue Market Share by Manufacturer in 2024
Figure 30. Others Revenue Market Share by Manufacturer in 2024
Figure 31. Global Dissolving Microneedle Sales Market Share by Type (2020-2031)
Figure 32. Global Dissolving Microneedle Revenue Market Share by Type (2020-2031)
Figure 33. Global Dissolving Microneedle Sales Market Share by Application (2020-2031)
Figure 34. Global Dissolving Microneedle Revenue Market Share by Application (2020-2031)
Figure 35. North America Dissolving Microneedle Sales YoY (2020-2031) & (K Units)
Figure 36. North America Dissolving Microneedle Revenue YoY (2020-2031) & (US$ Million)
Figure 37. North America Top 5 Manufacturers Dissolving Microneedle Sales Revenue (US$ Million) in 2024
Figure 38. North America Dissolving Microneedle Sales Volume (K Units) by Type (2020- 2031)
Figure 39. North America Dissolving Microneedle Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 40. North America Dissolving Microneedle Sales Volume (K Units) by Application (2020-2031)
Figure 41. North America Dissolving Microneedle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. US Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 43. Canada Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 44. Mexico Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 45. Europe Dissolving Microneedle Sales YoY (2020-2031) & (K Units)
Figure 46. Europe Dissolving Microneedle Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Europe Top 5 Manufacturers Dissolving Microneedle Sales Revenue (US$ Million) in 2024
Figure 48. Europe Dissolving Microneedle Sales Volume (K Units) by Type (2020-2031)
Figure 49. Europe Dissolving Microneedle Sales Revenue (US$ Million) by Type (2020-2031)
Figure 50. Europe Dissolving Microneedle Sales Volume (K Units) by Application (2020-2031)
Figure 51. Europe Dissolving Microneedle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. Germany Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 53. France Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 54. U.K. Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 55. Italy Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 56. Russia Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Dissolving Microneedle Sales YoY (2020-2031) & (K Units)
Figure 58. Asia-Pacific Dissolving Microneedle Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Top 8 Manufacturers Dissolving Microneedle Sales Revenue (US$ Million) in 2024
Figure 60. Asia-Pacific Dissolving Microneedle Sales Volume (K Units) by Type (2020- 2031)
Figure 61. Asia-Pacific Dissolving Microneedle Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 62. Asia-Pacific Dissolving Microneedle Sales Volume (K Units) by Application (2020-2031)
Figure 63. Asia-Pacific Dissolving Microneedle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 64. Indonesia Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 65. Japan Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 66. South Korea Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 67. China Taiwan Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 68. India Dissolving Microneedle Revenue (2020-2031) & (US$ Million)
Figure 69. Central and South America Dissolving Microneedle Sales YoY (2020-2031) & (K Units)
Figure 70. Central and South America Dissolving Microneedle Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Central and South America Top 5 Manufacturers Dissolving Microneedle Sales Revenue (US$ Million) in 2024
Figure 72. Central and South America Dissolving Microneedle Sales Volume (K Units) by Type (2021-2031)
Figure 73. Central and South America Dissolving Microneedle Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Central and South America Dissolving Microneedle Sales Volume (K Units) by Application (2020-2031)
Figure 75. Central and South America Dissolving Microneedle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. Brazil Dissolving Microneedle Revenue (2020-2025) & (US$ Million)
Figure 77. Argentina Dissolving Microneedle Revenue (2020-2025) & (US$ Million)
Figure 78. Middle East, and Africa Dissolving Microneedle Sales YoY (2020-2031) & (K Units)
Figure 79. Middle East and Africa Dissolving Microneedle Revenue YoY (2020-2031) & (US$ Million)
Figure 80. Middle East and Africa Top 5 Manufacturers Dissolving Microneedle Sales Revenue (US$ Million) in 2024
Figure 81. Middle East and Africa Dissolving Microneedle Sales Volume (K Units) by Type (2021-2031)
Figure 82. South America Dissolving Microneedle Sales Revenue (US$ Million) by Type (2020-2031)
Figure 83. Middle East and Africa Dissolving Microneedle Sales Volume (K Units) by Application (2020-2031)
Figure 84. Middle East and Africa Dissolving Microneedle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 85. GCC Countries Dissolving Microneedle Revenue (2020-2025) & (US$ Million)
Figure 86. Turkey Dissolving Microneedle Revenue (2020-2025) & (US$ Million)
Figure 87. Egypt Dissolving Microneedle Revenue (2020-2025) & (US$ Million)
Figure 88. South Africa Dissolving Microneedle Revenue (2020-2025) & (US$ Million)
Figure 89. Dissolving Microneedle Industry Chain Mapping
Figure 90. Regional Dissolving Microneedle Manufacturing Base Distribution (%)
Figure 91. Global Dissolving Microneedle Production Market Share by Region (2020-2031)
Figure 92. Dissolving Microneedle Production Process
Figure 93. Regional Dissolving Microneedle Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Dissolving Microneedle market?
The top companies in the global Dissolving Microneedle market are Micron Biomedical、BioSerenTach、Quadmedicine.
Related Reports
Dissolving Microneedle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dissolving Microneedle was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 130
USD 3950.00
(Single User License)
Global Dissolving Microneedle Market Research Report 2026
The global Dissolving Microneedle market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 113
USD 2900.00
(Single User License)
Global Dissolving Microneedle Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dissolving Microneedle market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
Dissolving Microneedle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dissolving Microneedle was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 101
USD 3950.00
(Single User License)
Global Dissolving Microneedle Market Research Report 2025
The global market for Dissolving Microneedle was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 84
USD 2900.00
(Single User License)
Global Dissolving Microneedle Market Research Report 2024
The global Dissolving Microneedle market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 78
USD 2900.00
(Single User License)
Dissolving Microneedle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dissolving Microneedle was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 130
USD 3950.00 (Single User License)Global Dissolving Microneedle Market Research Report 2026
The global Dissolving Microneedle market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 113
USD 2900.00 (Single User License)Global Dissolving Microneedle Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dissolving Microneedle market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
USD 4250.00 (Single User License)Dissolving Microneedle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dissolving Microneedle was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 101
USD 3950.00 (Single User License)Global Dissolving Microneedle Market Research Report 2025
The global market for Dissolving Microneedle was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 84
USD 2900.00 (Single User License)Global Dissolving Microneedle Market Research Report 2024
The global Dissolving Microneedle market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 78
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now